{"id":10650,"date":"2018-06-12T10:43:50","date_gmt":"2018-06-12T14:43:50","guid":{"rendered":"https:\/\/medicarereport.org\/?p=10650"},"modified":"2018-06-12T10:43:50","modified_gmt":"2018-06-12T14:43:50","slug":"a-serious-new-hurdle-for-crispr-edited-cells-might-cause-cancer-two-studies-find","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=10650","title":{"rendered":"A serious new hurdle for CRISPR: Edited cells might cause cancer, two studies find"},"content":{"rendered":"<p>(By Sharon Begley for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">Editing cells\u2019 genomes with CRISPR-Cas9 might increase the risk that\u00a0the altered cells,\u00a0intended to treat disease, will trigger cancer, two studies published on Monday warn \u2014 a potential game-changer for the companies developing CRISPR-based therapies. <a href=\"https:\/\/www.statnews.com\/2018\/06\/11\/crispr-hurdle-edited-cells-might-cause-cancer\/?_hsenc=p2ANqtz--tRLRBoLuE19nign6X_sNCkXMamwCZfAENL5g5j_CLfNKYikaqqLzYd25FtglM5OwSECeok96KD_2eaLlvuky8I6TymQ&amp;_hsmi=63687798\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Sharon Begley for STAT) Editing cells\u2019 genomes with CRISPR-Cas9 might increase the risk that\u00a0the altered cells,\u00a0intended to treat disease,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-10650","post","type-post","status-publish","format-standard","hentry","category-medical-technology"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10650"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10650\/revisions"}],"predecessor-version":[{"id":10651,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10650\/revisions\/10651"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}